No Way To Go But Grow: J&J Outlines Plans To Become A $60bn Pharma In 2025

 
• By Jessica Merrill
  
Janssen Pharmaceutica sign and logo
J&J outlined growth plans for its Janssen pharmaceutical unit • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business